Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Righttothetopon Dec 18, 2020 11:00am
101 Views
Post# 32139797

RE:RE:RE:RE:RE:RE:Technical420 report

RE:RE:RE:RE:RE:RE:Technical420 reportI see....you clearly don't understand that a double negative actually means a positive....ie. they don't like a cfo that won't cook the books is the same as saying that they like a cfo to cook the books....so digest that however you like....the not-so-subtle nuances of the English language seem to fail you....

As for 'proof' of double booking.....prove it....and hopefully not with more opinion or tweets from your alter-ego.....

Keep it transparent fladdi....doing great....

allibabba wrote: Ok right!  First of all my comment was "they don't like cfo's that won't cook the books".  Never once said the cfo cooked the books, so that's out of the way.  Secondly, there is proof that labs and cronos had "accounting discrepancies" and had to re-adjust earnings because of double booking revenue from flower and oils changing hands between the companies.  Digest it however you want.


<< Previous
Bullboard Posts
Next >>